Skip to main content
Clinical Trials/JPRN-UMIN000017170
JPRN-UMIN000017170Completed未知

A multicenter pilot study of antithymocyte globulin in patients undergoing allogeneic peripheral blood stem cell transplantation - NJHSG-ATG

orth Japan Hematology Study Group (NJHSG)0 sites6 target enrollmentStarted: April 19, 2015Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
6

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
16years-old to 65years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1. Patients who are positive for HBs antigen or HIV antibody. 2. Patients with severe mental illness 3. Women who are pregnant, of childbearing potential, or lactating. 4. Patients with active other malignancies. 5. Patients with active infectious disease. 6. Patients who had a history of myocardial infarction, or who needed treatment for heart failure within 1 year. 7. Patients with cirrhosis 8. Obese patients (body mass index [BMI; 35 or greater]) 9. Patients with arrhythmia (CTCAE Grade 3 or more) 10. Patients who experienced serious hypersensitivity or anaphylaxis to antithymocyte globulin. 11. Patients who are not eligible for this study at the discretion of the investigator.

Investigators

Sponsor
orth Japan Hematology Study Group (NJHSG)

Similar Trials